Literature DB >> 19059838

Autophagy in load-induced heart disease.

Beverly A Rothermel1, Joseph A Hill.   

Abstract

The heart is a highly plastic organ capable of remodeling in response to changes in physiological or pathological demand. For example, when workload increases, compensatory hypertrophic growth of individual cardiomyocytes occurs to increase cardiac output. Sustained stress, however, such as that occurring with hypertension or following myocardial infarction, triggers changes in energy metabolism and sarcomeric protein composition, loss of cardiomyocytes, ventricular dilation, reduced pump function, and ultimately heart failure. It has been known for some time that autophagy is active in cardiomyocytes, occurring at increased levels in disease. Now, with recent advances in our understanding of molecular mechanisms governing autophagy, the potential contributions of cardiomyocyte autophagy to ventricular remodeling and disease pathogenesis are being explored. As part of this work, several recent studies have focused on autophagy in heart disease elicited by changes in hemodynamic load. Pressure overload stress elicits a robust autophagic response in cardiomyocytes that is maladaptive, contributing to disease progression. In this context, load-induced aggregation of intracellular proteins is a proximal event triggering autophagic clearance mechanisms. These findings in the setting of pressure overload contrast with protein aggregation occurring in a model of protein chaperone malfunction, where activation of autophagy is beneficial, antagonizing disease progression. Here, we review recent studies of cardiomyocyte autophagy in load-induced disease and address molecular mechanisms and unanswered questions.

Entities:  

Mesh:

Year:  2008        PMID: 19059838      PMCID: PMC2607044          DOI: 10.1161/CIRCRESAHA.108.186551

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  75 in total

Review 1.  Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.

Authors:  Andrea Williams; Luca Jahreiss; Sovan Sarkar; Shinji Saiki; Fiona M Menzies; Brinda Ravikumar; David C Rubinsztein
Journal:  Curr Top Dev Biol       Date:  2006       Impact factor: 4.897

2.  Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes.

Authors:  Anne Hamacher-Brady; Nathan R Brady; Roberta A Gottlieb
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

Review 3.  Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation.

Authors:  Eric N Olson; Johannes Backs; Timothy A McKinsey
Journal:  Novartis Found Symp       Date:  2006

Review 4.  The fuzzy logic of physiological cardiac hypertrophy.

Authors:  Gerald W Dorn
Journal:  Hypertension       Date:  2007-03-26       Impact factor: 10.190

5.  Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.

Authors:  Yan G Ni; Kambeez Berenji; Na Wang; Misook Oh; Nita Sachan; Asim Dey; Jun Cheng; Guangrong Lu; David J Morris; Diego H Castrillon; Robert D Gerard; Beverly A Rothermel; Joseph A Hill
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

6.  Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy.

Authors:  Yutaka Matsui; Hiromitsu Takagi; Xueping Qu; Maha Abdellatif; Hideyuki Sakoda; Tomoichiro Asano; Beth Levine; Junichi Sadoshima
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

7.  The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.

Authors:  Atsuko Nakai; Osamu Yamaguchi; Toshihiro Takeda; Yoshiharu Higuchi; Shungo Hikoso; Masayuki Taniike; Shigemiki Omiya; Isamu Mizote; Yasushi Matsumura; Michio Asahi; Kazuhiko Nishida; Masatsugu Hori; Noboru Mizushima; Kinya Otsu
Journal:  Nat Med       Date:  2007-04-22       Impact factor: 53.440

Review 8.  Thioredoxin1 as a negative regulator of cardiac hypertrophy.

Authors:  Tetsuro Ago; Junichi Sadoshima
Journal:  Antioxid Redox Signal       Date:  2007-06       Impact factor: 8.401

Review 9.  Glycogen synthase kinase-3beta -- actively inhibiting hypertrophy.

Authors:  Risto Kerkelä; Kathleen Woulfe; Thomas Force
Journal:  Trends Cardiovasc Med       Date:  2007-04       Impact factor: 6.677

Review 10.  The roles of intracellular protein-degradation pathways in neurodegeneration.

Authors:  David C Rubinsztein
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

View more
  89 in total

Review 1.  Hold me tight: Role of the heat shock protein family of chaperones in cardiac disease.

Authors:  Monte S Willis; Cam Patterson
Journal:  Circulation       Date:  2010-10-26       Impact factor: 29.690

2.  Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: insights from zebrafish genetics.

Authors:  Yonghe Ding; Xiaojing Sun; Margaret Redfield; Sudhir Kushwaha; Xiaolei Xu
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

Review 3.  Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.

Authors:  Monte S Willis; W H Davin Townley-Tilson; Eunice Y Kang; Jonathon W Homeister; Cam Patterson
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

Review 4.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

Review 5.  Mitochondrial fission and autophagy in the normal and diseased heart.

Authors:  Myriam Iglewski; Joseph A Hill; Sergio Lavandero; Beverly A Rothermel
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

6.  Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia.

Authors:  Neetu Tyagi; Jonathan C Vacek; Srikanth Givvimani; Utpal Sen; Suresh C Tyagi
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

7.  Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish.

Authors:  Yonghe Ding; Xiaojing Sun; Wei Huang; Tiffany Hoage; Margaret Redfield; Sudhir Kushwaha; Sridhar Sivasubbu; Xueying Lin; Stephen Ekker; Xiaolei Xu
Journal:  Circ Res       Date:  2011-07-14       Impact factor: 17.367

Review 8.  Posttranslational modification and quality control.

Authors:  Xuejun Wang; J Scott Pattison; Huabo Su
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

9.  Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling.

Authors:  Rimpy Dhingra; Victoria Margulets; Subir Roy Chowdhury; James Thliveris; Davinder Jassal; Paul Fernyhough; Gerald W Dorn; Lorrie A Kirshenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 10.  Target of rapamycin (TOR)-based therapy for cardiomyopathy: evidence from zebrafish and human studies.

Authors:  Sudhir Kushwaha; Xiaolei Xu
Journal:  Trends Cardiovasc Med       Date:  2012-07-28       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.